tradingkey.logo

GRI Bio Inc <GRI.OQ> expected to post a loss of $1.31 a share - Earnings Preview

ReutersAug 8, 2025 3:53 PM
  • GRI Bio Inc GRI.OQ GRI.O is expected to report resultson August 12 (estimated) for the period ending June 30 2025

  • ​LSEG's mean analyst estimate for GRI Bio Inc is for a loss of $1.31 per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for GRI Bio Inc is $102.00, about 98.8% above its last closing price of $1.25

This summary was machine generated August 8 at 15:53 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Tradingkey
KeyAI